Uterine Neoplasms

"Uterine Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the UTERUS.

Descriptor ID	D014594
MeSH Number(s)	C04.588.945.418.948 C13.351.500.852.762 C13.351.937.418.875
Concept/Terms	Uterine Neoplasms Uterine Neoplasms Neoplasms, Uterus Neoplasm, Uterus Uterus Neoplasm Uterus Neoplasms Neoplasms, Uterine Neoplasm, Uterine Uterine Neoplasm Cancer of Uterus Cancer of Uterus Uterus Cancers Cancer of the Uterus Uterus Cancer Cancer, Uterus Cancers, Uterus Uterine Cancer Cancer, Uterine Cancers, Uterine Uterine Cancers

Below are MeSH descriptors whose meaning is more general than "Uterine Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Urogenital Neoplasms [C04.588.945]
Genital Neoplasms, Female [C04.588.945.418]
Uterine Neoplasms [C04.588.945.418.948]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Genital Diseases, Female [C13.351.500]
Uterine Diseases [C13.351.500.852]
Uterine Neoplasms [C13.351.500.852.762]
Urogenital Neoplasms [C13.351.937]
Genital Neoplasms, Female [C13.351.937.418]
Uterine Neoplasms [C13.351.937.418.875]

Below are MeSH descriptors whose meaning is related to "Uterine Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Uterine Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Uterine Neoplasms" by people in this website by year, and whether "Uterine Neoplasms" was a major or minor topic of these publications.

Bar chart showing 43 publications over 16 distinct years, with a maximum of 6 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	2	0	2
2003	2	1	3
2004	1	0	1
2005	0	1	1
2007	3	0	3
2008	3	1	4
2009	1	0	1
2010	3	0	3
2011	1	0	1
2012	4	0	4
2014	4	0	4
2015	3	0	3
2016	4	0	4
2017	6	0	6
2018	1	0	1
2019	1	1	2

Below are the most recent publications written about "Uterine Neoplasms" by people in Profiles.

Borden LE, McCuin ES, Sheth PD, Iglesias DA. Rare Case of Mixed Metastatic Placental Site Trophoblastic Tumor and Choriocarcinoma. J Oncol Pract. 2019 09; 15(9):505-506.

View in: PubMed
Schnell E, Thompson S, Ahmad S, Herman TS, De La Fuente Herman T. Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy. Med Dosim. 2020 Spring; 45(1):21-27.

View in: PubMed
Cardozo ER, Foster R, Karmon AE, Lee AE, Gatune LW, Rueda BR, Styer AK. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma. Reprod Biol Endocrinol. 2018 May 11; 16(1):46.

View in: PubMed
Rasool N, Lefebvre DR, Latina MA, Dunn IF, Santagata S, Freitag SK, Cestari DM. Orbital leiomyosarcoma metastasis presenting prior to diagnosis of the primary tumor. Digit J Ophthalmol. 2017; 23(4):22-26.

View in: PubMed
Gee MS, Atri M, Bandos AI, Mannel RS, Gold MA, Lee SI. Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial. Radiology. 2018 04; 287(1):176-184.

View in: PubMed
Holman LL, Pal N, Iglesias DA, Soliman PT, Balakrishnan N, Klopp A, Broaddus RR, Fleming ND, Munsell MF, Lu KH, Westin SN. Factors prognostic of survival in advanced-stage uterine serous carcinoma. Gynecol Oncol. 2017 07; 146(1):27-33.

View in: PubMed
Cherniack AD, Shen H, Walter V, Stewart C, Murray BA, Bowlby R, Hu X, Ling S, Soslow RA, Broaddus RR, Zuna RE, Robertson G, Laird PW, Kucherlapati R, Mills GB, Weinstein JN, Zhang J, Akbani R, Levine DA. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017 03 13; 31(3):411-423.

View in: PubMed
Kopp RP, Stratton KL, Glogowski E, Schrader KA, Rau-Murthy R, Russo P, Coleman JA, Offit K. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma. Cancer. 2017 Jul 01; 123(13):2452-2458.

View in: PubMed
Styer AK, Jin S, Liu D, Wang B, Polotsky AJ, Christianson MS, Vitek W, Engmann L, Hansen K, Wild R, Legro RS, Coutifaris C, Alvero R, Robinson RD, Casson P, Christman GM, Christy A, Diamond MP, Eisenberg E, Zhang H, Santoro N. Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility. Fertil Steril. 2017 Mar; 107(3):756-762.e3.

View in: PubMed
Winder AD, Maniar KP, Wei JJ, Liu D, Scholtens DM, Lurain JR, Schink JC, Buttin BM, Filiaci VL, Lankes HA, Ramirez NC, Park K, Singh M, Lieberman RW, Mannel RS, Powell MA, Backes FJ, Mathews CA, Pearl ML, Secord AA, Peace DJ, Mutch DG, Creasman WT, Kim JJ. Synuclein-? in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study. Cancer. 2017 04 01; 123(7):1144-1155.

View in: PubMed

People

Explore

Similar Concepts

Top Journals